Acrux Ltd

ACR

Company Profile

  • Business description

    Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline products include Lenzetto, Evamist, Testosterone Topical Solution, and among others.

  • Contact

    103-113 Stanley Street
    West Melbourne
    MelbourneVIC3003
    AUS

    T: +61 383790100

    E: [email protected]

    https://www.acrux.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

    36

Stocks News & Analysis

stocks

The ‘other’ AI chip behemoth that might just be getting started

The magnitude of growth at Broadcom continues to astound us.
stocks

Why ANZ changes aren’t just about cutting costs

The banking major needs to prevent key product offerings from falling further behind the competition.
stocks

Strong finish to the year for overvalued ASX share

A great fiscal 2025 but investors are ahead of themselves.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,095.2028.800.32%
CAC 407,772.8823.490.30%
DAX 4023,775.5257.070.24%
Dow JONES (US)45,711.34196.390.43%
FTSE 1009,261.5419.010.21%
HKSE26,200.26262.131.01%
NASDAQ21,879.4980.790.37%
Nikkei 22543,837.67378.380.87%
NZX 50 Index13,276.2422.510.17%
S&P 5006,512.6117.460.27%
S&P/ASX 2008,830.4040.000.46%
SSE Composite Index3,812.224.930.13%

Market Movers